Fitzgibbon Dermot R, Posner Karen L, Domino Karen B, Caplan Robert A, Lee Lorri A, Cheney Frederick W
Department of Anesthesiology, University of Washington, Seattle, 98195-6540, USA.
Anesthesiology. 2004 Jan;100(1):98-105. doi: 10.1097/00000542-200401000-00018.
The practice of chronic pain management has grown steadily in recent years. The purpose of this study was to identify and describe issues and trends in liability related to chronic pain management by anesthesiologists.
Data from 5,475 claims in the American Society of Anesthesiologists Closed Claims Project database between 1970 and 1999 were reviewed to compare liability related to chronic pain management with that related to surgical and obstetric (surgical/obstetric) anesthesia. Acute pain management claims were excluded from analysis. Outcomes and liability characteristics between 284 pain management claims and 5,125 surgical/obstetric claims were compared.
Claims related to chronic pain management increased over time (P < 0.01) and accounted for 10% of all claims in the 1990s. Compensatory payment amounts were lower in chronic pain management claims than in surgical/obstetric anesthesia claims from 1970 to 1989 (P < 0.05), but during the 1990s, there was no difference in size of payments. Nerve injury and pneumothorax were the most common outcomes in invasive pain management claims. Epidural steroid injections accounted for 40% of all chronic pain management claims. Serious injuries, involving brain damage or death, occurred with epidural steroid injections with local anesthetics and/or opioids and with maintenance of implantable devices.
Frequency and payments of claims associated with chronic pain management by anesthesiologists increased in the 1990s. Brain damage and death were associated with epidural steroid injection only when opioids or local anesthetics were included. Anesthesiologists involved in home care of patients with implanted devices such as morphine pumps and epidural injections or patient-controlled analgesia should be aware of potential complications that may have severe outcomes.
近年来,慢性疼痛管理的业务稳步增长。本研究的目的是识别和描述麻醉医生在慢性疼痛管理方面的责任问题及趋势。
回顾了美国麻醉医师协会封闭索赔项目数据库中1970年至1999年间5475份索赔数据,以比较慢性疼痛管理相关责任与外科和产科(手术/产科)麻醉相关责任。急性疼痛管理索赔被排除在分析之外。比较了284份疼痛管理索赔与5125份手术/产科索赔的结果及责任特征。
与慢性疼痛管理相关的索赔随时间增加(P < 0.01),在20世纪90年代占所有索赔的10%。1970年至1989年,慢性疼痛管理索赔的赔偿金额低于手术/产科麻醉索赔(P < 0.05),但在20世纪90年代,赔偿金额大小没有差异。神经损伤和气胸是侵入性疼痛管理索赔中最常见的结果。硬膜外类固醇注射占所有慢性疼痛管理索赔的40%。硬膜外注射局部麻醉剂和/或阿片类药物以及植入装置维护时发生了涉及脑损伤或死亡的严重伤害。
20世纪90年代,麻醉医生与慢性疼痛管理相关的索赔频率和赔偿金额增加。仅当包含阿片类药物或局部麻醉剂时,脑损伤和死亡才与硬膜外类固醇注射相关。参与植入装置(如吗啡泵和硬膜外注射或患者自控镇痛)患者家庭护理的麻醉医生应意识到可能产生严重后果的潜在并发症。